Shandong New Time Pharmaceutical Co., LTD Report issue

Government Phase 1 Phase 2 Phase 3

Organization Overview

First Clinical Trial
2018
NCT03657381
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Shandong New Time Pharmaceutical Co., LTD